{
    "2018-09-10": [
        [
            {
                "time": "",
                "original_text": "恒瑞医药：盐酸坦索罗辛缓释胶囊通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "盐酸坦索罗辛",
                        "仿制药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "8月医药大事件之榜单篇：特色排行榜增多，更具参考价值",
                "features": {
                    "keywords": [
                        "8月",
                        "医药",
                        "大事件",
                        "排行榜",
                        "参考价值"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "财经汇·个股研报精选",
                "features": {
                    "keywords": [
                        "财经汇",
                        "个股研报",
                        "精选"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【陆股通交易追踪】陆股通合计净流出2.54亿元 医药生物股遭减仓",
                "features": {
                    "keywords": [
                        "陆股通",
                        "净流出",
                        "医药生物",
                        "减仓"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "证监会年内首批两公司QFII资格 大数据揭秘外资长期投资图谱",
                "features": {
                    "keywords": [
                        "证监会",
                        "QFII",
                        "资格",
                        "大数据",
                        "外资",
                        "长期投资"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泓德基金邬传雁：在投资的各个环节放眼长远",
                "features": {
                    "keywords": [
                        "泓德基金",
                        "邬传雁",
                        "投资",
                        "长远"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}